Literature DB >> 16962913

Thrombophilia and women's health: An overview.

Isaac Blickstein1.   

Abstract

Thrombophilia, whether inherited or acquired, is one of the hot topics in women's health. Several factors, some of which are specific to the female patient, enhance thrombus formation in the presence of thrombophilia and include oral contraception, hormone replacement therapy, pregnancy, and puerperium. Thrombotic events are not only restricted to venous thromboembolism but also are believed to cause repeated embryonic loss, fetal loss, placental abruption, intrauterine growth restriction, and severe pre-eclampsia. It seems that some thrombophilias, and a combination of thrombophilic factors, carry a greater risk than others for a given adverse outcome. The addition of LMWH to the armamentarium was associated with conceptual change in the practice of anticoagulation. Care should be exercised in the interpretation of various risks and the potential of anticoagulation as a remedy to reduce that risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962913     DOI: 10.1016/j.ogc.2006.05.003

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  5 in total

1.  Magnetic resonance venography and genetics of a female patient with pelvic venous thrombosis.

Authors:  Thomas G Perkins; Rahul K Mishra; Yasmin Siddiqui; Eric H Hanson; Robb K Rowley; Erica R Ramos; William W Orrison
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

2.  Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis.

Authors:  Jeffrey T Jensen; Anne E Burke; Kurt T Barnhart; Carrie Tillotson; Marci Messerle-Forbes; Dawn Peters
Journal:  Contraception       Date:  2008-08-28       Impact factor: 3.375

3.  The significance of genetic polymorphisms of factor V Leiden and prothrombin in the preeclamptic Polish women.

Authors:  Agnieszka Seremak-Mrozikiewicz; Krzysztof Drews; Ewa Wender-Ozegowska; Przemyslaw M Mrozikiewicz
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

4.  Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.

Authors:  Christine Klipping; Ingrid Duijkers; Susanne Parke; Uwe Mellinger; Marco Serrani; Wolfgang Junge
Journal:  Drugs R D       Date:  2011

5.  Hormonal anticonception anno 2013: a clinician's view.

Authors:  M Dhont; V Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.